Novo Nordisk Seeks to Expand Liver Disease Treatments in $5.2B Deal for Bay Area Biotech
Novo Nordisk has reshaped countless waistlines. Now the Ozempic maker is aiming a little higher in the abdomen. The Danish...
Nordisk
Novo Nordisk Soars After 50% Ozempic Discount, Liver Treatment Approval
Cash truly is king. On Monday, shares in Novo Nordisk jumped 4% after the drugmaker announced that US customers who...
